Definium Therapeutics (DFTX) Intangibles (2021 - 2023)

Definium Therapeutics (DFTX) has 3 years of Intangibles data on file, last reported at $527000.0 in Q4 2023.

• On a quarterly basis, Intangibles fell 85.71% year-over-year to $527000.0 in Q4 2023; TTM through Dec 2023 was $527000.0, a 85.71% decrease from a year earlier, with the FY2023 full-year figure at $527000.0, down 85.71% from the prior year.
• Intangibles for Q4 2023 stood at $527000.0, down from $1.3 million in the prior quarter.
• Over the last five years, Intangibles for DFTX reached as high as $6.9 million in Q4 2021 and fell as low as $527000.0 in Q4 2023.
• Historically, Intangibles has averaged $3.7 million across 3 years, with a median of $3.7 million in 2022.
• Across the five-year window, Intangibles slumped 46.29% in 2022 and slumped 85.71% in 2023, its largest moves.
• Year by year, Intangibles stood at $6.9 million in 2021, then slumped by 46.29% to $3.7 million in 2022, then sank by 85.71% to $527000.0 in 2023.
• Per Business Quant data, the three most recent Intangibles figures were $527000.0 in Q4 2023, $1.3 million in Q3 2023, and $2.1 million in Q2 2023.